Table 3.
Participants’ Unadjusted Psychosocial, Symptom, and Medication Adherence Scores at Baseline and Study Exit.
| Variable | N | Baseline, Mean (SD) | Exit, Mean (SD) | Mean Difference (95% CL) | P Value |
|---|---|---|---|---|---|
| BCPT total score | 37 | 0.71 (0.54) | 0.75 (0.51) | 0.04 (−0.06, 0.14) | .412 |
| Concerns about Recurrence score | 37 | 10.86 (6.55) | 9.73 (4.95) | −1.14 (−2.31, 0.04) | .057 |
| CASE 3-item score | 36 | 27.83 (3.20) | 27.78 (4.36) | −0.06 (−1.67, 1.56) | .944 |
| CES-D score | 31 | 6.90 (9.05) | 5.68 (7.96) | −1.23 (−3.47, 1.01) | .272 |
| Brief Pain Inventory (BPI) score | 11 | 2.84 (2.78) | 3.63 (2.61) | 0.79 (−0.44, 2.02) | .182 |
| Fatigue Symptom Inventory (FSI) score | 36 | 1.82 (2.20) | 1.57 (1.97) | −0.25 (−0.76, 0.26) | .322 |
| SF-8 MCS mental subscale score | 36 | 49.95 (7.81) | 52.98 (6.51) | 3.03 (0.87, 5.18) | .007 |
| SF-8 PCS physical subscale score | 36 | 45.44 (10.27) | 46.39 (10.58) | 0.95 (−1.71, 3.61) | .473 |
| Perceived Stress Scale (PSS) score | 36 | 17.14 (9.39) | 15.64 (8.24) | −1.50 (−2.93, −0.07) | .040 |
| Social Desirability Response score | 37 | 21.62 (1.75) | 21.41 (2.20) | −0.22 (−0.99, 0.56) | .577 |
| MOS Social Support score | 36 | 89.58 (10.23) | 90.94 (9.35) | 1.36 (−0.70, 3.42) | .189 |
| Morisky Adherence score | 36 | 1.92 (1.70) | 1.17 (1.32) | −0.75 (−1.35, −0.15) | .015 |
Abbreviations: BCPT, Breast Cancer Prevention Trial Symptom Checklist; CASE, Communication and Attitudinal Self-Efficacy; CES-D, Center for Epidemiological Studies Depression; MCS, Mental Health Component Summary; PSS, Perceived Stress Score; MOS, Medical Outcomes Study; SD, standard deviation.